Alpha-enolase (ENO1) were previously reported to promote metastasis of lung cancer via HGDR and Wnt signaling pathway [34] and higher anti-ENO1 antibody level was associated with better progression-free survival in non-small cell lung carcinoma (NSCLC) patients after surgery [35]. Here, ENO1 is linked to non-small cell lung carcinoma.